Reason for referral: provide patient education on management of hypoglycemia and glucose monitor
|
|
- Benjamin Hodge
- 5 years ago
- Views:
Transcription
1 Meet Robin Sawyer (otherwise known as PT 1): Let s Create a Care Plan! Reason for referral: provide patient education on management of hypoglycemia and glucose monitor History of present illness: yo lawyer, 6 2, 210 lbs (BMI 27), diagnosed with type 2 diabetes 6 yrs ago. His GP recently started long acting insulin glargine (Lantus ) once daily at bedtime. Robin was instructed to check his blood glucose more often. With his busy lifestyle and work schedule, Robin doesn t feel he ll be able to do it. He is unsure of how often and what times of day. He finds it difficult to have a meter with him at all times (home, office, court, lunch meetings). Sometimes, he doesn t know if the strips are expired and if they can be used past the expiration date. He is worried he experienced a couple episodes of low blood sugar (based on dizziness) in last week, yet he could not verify. He wants to know if testing all the time is necessary and what the latest research says. Past Medical History: Dyslipidemia HTN DM No history of CVD Tonsillectomy at age 2 7 Leg fracture, age Medication Allergies: NKDA Medication History: Indication Drug Name Directions Adherence (Y/N) Notes/Comments Diabetes Metformin 1000 mg BID (AM and supper) Y, except noon Taken x 6 years 500 mg at noon dose often missed Diabetes Gliclazide 80 mg BID (AM and supper) Y Taken x 5 years Diabetes Insulin glargine (Lantus ) 10 units qhs Y Started 1 month ago; tolerating injections Hyperlipidemia Atorvastatin 10 mg QHS Y Taken X 2 years Hypertension Ramipril 10 mg QAM Y Started 3 years ago No OTC use (and specifically does not take aspirin) Receives yearly influenza vaccine Organizes medications himself; does not use dosette or blister pack Generally remembers to take his medications Is not bothered that he takes chronic medications; generally feels well except for some recent dizzy spells Social History: (+) smoking: 5 6 cigarettes/day x past year (1ppd x 20 years prior to this), cigar on the weekend at the country club. Tried quitting in the past but the stress of the job makes it difficult. Diet: eats breakfast and supper routinely; sometimes misses lunch due to busy schedule. Tries to eat DM diet. EtOh: nil Occupation: lawyer Married, 2 teenage children Family History: (+) diabetes maternal grandmother, father Strong family history of heart disease (Dad, MI, age 50; Mom, stroke, age 60)
2 Review of Systems CNS: occ. light headedness and dizziness which he thinks may be associated with low FPG from skipping meals, but does not check with meter. No HA reported. CVS: BP (MD office last week) 128/80, HR 70 bpm; does not use home BP monitor Resp: no concerns Abdo: mild central obesity, lost 30 lbs in last 6 yrs since diagnosed with DM. Normal BM; no N/V General: overall, has increased stress related to his occupation. Investigations Labs (taken last week as per physician request) Parameter Actual Normal Range Na 142 mmol/l mmol/l K 4.1 mmol/l mmol/l Scr 102 umol/l umol/l BUN 4.3 umol/l LDL 1.66 mmo/l Treatment Goals HDL 1.13 mmo/l T CHol 4.09 mmo/l Trig 2.87 mmo/l Total:HDL 3.6 ALT 15 U/L < 50 U/L AST ALP T Bili A1C 7.9 % % FPG 7.7 mmol/l mmol/l Hgb 136 g/l g/l WBC 5.2 x 10 9 /L 4 11 x 10 9 /L Urine Microalbumin/Creatinine ratio 0.1 mg/mmol < 2.0 mg/mmol For all patients, a primary target is a reduction of greater than or equal to 50% in the LDL cholesterol value. For patients classified as high or moderate risk, the primary target is a reduction of greater than or equal to 50% in the LDL cholesterol value or a LDL of < 2.0 mmol/l.
3 PHARMACY CARE PLAN WORKSHEET Robin Sawyer MEDICAL CONDITION AND/OR DRPs DM 1. Requires education about blood glucose monitoring (BGM) to use insulin safely 2. Appears to be experiencing hypoglycemia (dizziness) when meals skipped 3. A1C 7.9 which is suboptimal for him 4. Lifestyle and CV risk factors given he has DM see below GOALS OF THERAPY ALTERNATIVES RECOMMENDATIONS/ PLAN 1. Educate on importance of glucose monitoring for using insulin safely, and link between insulin use and potential for hypoglycemia. 2. Determine if dizziness caused by hypoglycemia. 3. Goal A1C<7: need to review BG pattern to see if patient is meeting ac and pc BG targets; need to minimize hypoglycemia while achieving this. 1. Education on glucose monitoring; No alternatives stress importance of BGM while on insulin and discuss strategies to implement 2. No alternatives; need to definitively determine if hypoglycemia is occurring *Consider hypotension as alternate explanation for dizziness. 3. Goal A1C while minimizing dizziness a. Based on ac and pc BG and A1C, may need to optimize insulin/oral regimen 1. Encourage BGM (qid initially including ac and pc lunch) to determine if low BG are likely causing dizzy spells. Use journal to track. Provided info on strips and expiry. New strips provided. 2. Suggested ways today to treat hypoglycemia if present (based on BGM) a. Sugar candies b. Eating regular meals 3. Sold additional (small) BGM for use in office (he didn t realize small monitors available) MONITORING PARAMETERS Short term: # of dizzy spells, when they occur, corresponding BGM data to confirm if dizziness is related to low BG Long term: address achieving A1C goal and modification/intensification of therapy to achieve this. Review BG levels once using a BGM. Re check A1C in 3 months (insulin newly started). CV Risk Assessment (Framingham 2008 version): high risk for primary prevention based on age <45 + DM and 3 other risk factors (HTN, smoking, positive family history) Dyslipidemia 1. LDL<2mmol/L: goal achieved None required goal met. (LDL Tolerability of atorvastatin mmol/l) 3. Adherence HTN Last BP reading 128/80 1. Goal < 130/80 (DM) 2. Implement Home BP Monitoring (HBPM) 3. Tolerability of ramipril 4. Adherence None required at this time goal met. (128/80) Ensure home BPs are controlled. 1. Continue atorvastatin 10 mg daily as prescribed. 2. Tolerating well (specifically no myopathy), ALT normal 1. Continue ramipril 10 mg daily 2. Tolerating ramipril, K+ 4.1, Scr 102 (unchanged from 1 yr ago), ACR N 3. Recommend purchasing home BP monitor in future 1. Alert us if concerns arise 2. Ensure LDL<2 mmol/l maintained annually 3. Adherence Deferred; patient will try HBPM in future once DM better controlled FOLLOW UP Short term: How: phone or in person depending on Robin s schedule When: 1 2 weeks Long term plan will be determined based on data gathered for current issue. Who: he will call if problem How: phone/person When: every 3 6 months for adherence, annually for lipid profile How: next inperson visit When: 1 4 months ASA indication for use? To reduce CV events, namely MI, while minimizing risk of bleeding 1. Aspirin mg daily PRO: will reduce total CV events by 12%, and MI by 23%. Given high risk status, he may benefit IF his risk of GI bleeding is low. Would need to explore next visit CON: No evidence in DM currently that dictates use of ASA without evidence of CVD, overall event rate low based on age, bleeding risk increased (GI and ICH) 1. Defer; will discuss with Robin next time we meet. Need to discuss bleeding history. Interest in using ASA after discussing benefits/risks with him. How: next inperson visit When: 1 4 months
4 Lifestyle changes 1. Smoking 2. Diet/weight 3. Exercise regimen 1. Assess readiness to quit smoking 2. Review diet/eating pattern and reinforce importance of losing weight (or not gaining weight) 3. Implement 30 minutes/day 3x/week (Robin feels this is doable) 1. Assessment/discussion of readiness versus no discussion depending on time frame 2. Suggest ways to incorporate eating through day to minimize hypoglycemia; promote DM diet 3. Discussed types of activities he likes: walking, tennis, biking 1. Not interested in quitting at this time; will consider in future. 2. Will try and have snacks/preprepared meals on hand for convenience 3. Will exercise starting 3x/wk 1. Smoking readiness toquit; discuss in future 2. Success of dietary changes 3. Success of exercise pattern How: next visit When: 1 2 months; focus on smoking cessation as he would like to achieve this in future
5 Example of Initial Consult Note Robin Sawyer (otherwise known as PT 1) DATA Reason for Referral: provide patient education on management of dizziness (?hypoglycemia) and home glucose monitor HPI: yo lawyer, 6 2, 210 lbs (BMI 27), diagnosed with type 2 diabetes x 6 yrs GP recently started long acting insulin glargine (Lantus ) HS. Instructed to check his blood glucose more often. With his busy lifestyle and work not been able to do it. He is unsure of how often and what times of day. He finds it difficult to have a glucometer with him at all times (home, office, court, lunch meetings). Also concerned strips are expired and wants to know if they can be used past expiration date Worried he experienced a couple episodes of low blood sugar (based on dizziness) in last week in early afternoon after skipping lunch, yet he could not verify. Wants to know if testing all the time is necessary and what the latest research says. Relevant Past Medical History: Dyslipidemia, HTN, No history of CVD Medication Allergies: NKDA Medication History: Indication Drug Name Directions Adherence (Y/N) Notes/Comments Diabetes Metformin 1000 mg BID (AM and supper) Y, except noon dose Taken x 6 years 500 mg at noon often missed Diabetes Gliclazide 80 mg BID (AM and supper) Y Taken x 5 years Diabetes Lantus insulin 10 units qhs Y Started 1 month ago; tolerating injections Hyperlipidemia Atorvastatin 10 mg QHS Y Taken X 2 years Hypertension Ramipril 10 mg QAM Y Started 3 years ago No OTC use and does not take daily aspirin; receives yearly influenza vaccine Med Management: organizes medications himself; does not use dosette or blister pack Social History: (+) smoking: 5 6 cigarettes/day x past year (1ppd x 20 years prior to this), cigar on the weekend at the country club. Tried quitting in the past but the stress of the job makes it difficult. Not interested in quitting at this time. Diet: eats breakfast and supper routinely; sometimes misses lunch due to busy schedule. Tries to eat DM diet. Family History: (+) DM maternal grandmother, father (+) family history CAD (Dad, MI, age 50; Mom, stroke, age 60) Review of Systems CNS: occ. light headedness and dizziness which he thinks may be associated with low FPG from skipping meals, but does not check with meter. No HA reported. CVS: BP (MD office last week) 128/80, HR 70 bpm; does not use home BP monitor Abdo: mild central obesity, lost 30 lbs in last 6 yrs since diagnosed with DM. Normal BM; no N/V
6 General: overall, has increased stress related to his occupation. Investigations Labs (taken last week as per physician request) Parameter Actual Normal Range K 4.1 mmol/l mmol/l Scr 102 umol/l umol/l LDL 1.66 mmo/l < 2 mmol/l ALT 15 U/L < 50 U/L A1C 7.9 % % FPG 7.7 mmol/l mmol/l Urine Microalbumin/Creatinine ratio 0.1 mg/mmol < 2.0 mg/mmol ASSESSMENT/PLAN 1. Education on proper blood glucose monitoring and its importance provided, especially when using insulin and experiencing dizziness. a. Agrees to purchasing new, small glucometer for use in the office b. Will record his FBG readings for review by pharmacist in 2 weeks. c. Important to check the glucose 3 4 times a day when insulin regimen is new, especially during episodes of dizziness and if insulin dose changes. If can only check bid, best times would be ac breakfast and hs. 2.?Hypoglycemia; obtain FBG readings periodically as well as during dizzy spells to verify if this is actual cause a. Avoid skipping lunch and try to have 6 small meals spread throughout day. b. Carry dextrose tablets or hard candies and use if feeling dizzy and FBG is low (less than 3.5 mmol/l) 3. Optimize A1C to less than 7 over next 3 6 months; A1C currently 7.9 a. Assess drug options after viewing FBG records b. Insulin dose may need to be changed; consider more intensive regimen c. Repeat A1C when appropriate in future 4. CV Risk Assessment high risk based on Framingham and UKPDS. Needs aggressive control of modifiable risk factors. a. Smoking cessation: defer. Aware of options to support him in quitting. b. Weight loss encouraged; goal BMI<25. Referral to dietician made. c. BP: goal less than 130/80. Suggest HBPM for use in future to ensure goal maintained. Follow Scr as elevated, but not different from baseline 1 year ago. K+ normal. ACR normal. d. LDL goal less than 2mmol/L; no change to atorvastatin as goal of less than 2 mmol/l achieved, ALT normal, tolerating atorvastatin well. e. Consider ASA therapy in future. FOLLOW UP: 1 2 weeks for reviewing FBG records and # dizzy spells. Will optimize his DM management then. Consider discussion of HBPM, smoking cessation and ASA.
7 Example Short Documentation for INTERNAL PHARMACY USE DATA yo with DMII, started on insulin glargine hs 1 month ago. Concerned about dizziness (?hypoglycemia) that occurs after skipping lunch. Also wants to know about use of home glucose monitor. HPI: Instructed to check blood glucose more often; with busy lifestyle, not happening. Unsure of how often and when. Difficult to have a glucometer with him at all times (home, office, court, lunch meetings). Relevant PMHx: Dyslipidemia, HTN, No Hx of CVD Medications (NKDA): metformin 1000 mg bid mg lunch, gliclazide 80 mg bid, insulin glargine 10 units hs, atorvastatin 10 mg daily, ramipril 10 mg qam. 100% adherent with all except noon metformin (occ. misses), No OTC use. No ASA use. Tolerates all meds. Cardiac Risk Factors: HTN (BP 128/80), DM, dyslipidemia, (+) smoking (5 6 cigarettes/day x past year, not interested in quitting at this time), +FHx CAD, Diet: sometimes misses lunch, lost 30 lbs in last year. Relevant Labs: K+ 4.1, Scr 102 (similar to Scr 1 year ago), LDL 1.66, ALT 15, A1C 7.9 ASSESSMENT/PLAN 1. Education on proper blood glucose monitoring and its importance provided, especially when using insulin and experiencing dizziness. a. Buys new monitor for use in the office, will record his FBG readings, important to check the glucose tid qid, (both ac and pc meals) esp during episodes of dizziness and if insulin dose changes. If only check bid, try ac breakfast and hs. 2.?Hypoglycemia; obtain FBG readings during dizzy spells to verify if this is actual cause a. Avoid skipping lunch and carry/use dextrose tablets/hard candies if feeling dizzy and FBG low (less than 3.5 mmol/l) 3. Goal A1C to less than 7 over next 3 6 months; Repeat A1C when appropriate 4. CV Risk Assessment high risk based on Framingham and UKPDS. Control modifiable risk factors. a. Smoking cessation: deferred b. Weight loss encouraged; goal BMI less than 25. Referral to dietician made. c. BP: goal less than 130/80. Suggest HBPM for use in future. Follow elevated Scr. K+ normal. d. LDL goal less than 2mmol/L achieved F/U: 1 2 weeks for reviewing FBG records and # dizzy spells. Optimize DM management then. Consider HBPM, smoking cessation and ASA.
Case Studies in T2DM A Comprehensive Management Approach
Case Studies in T2DM A Comprehensive Management Approach John E. Anderson, MD The Frist Clinic Nashville, TN 43 yo Latina woman with 5 yrs T2DM. Originally diagnosed with PCOS and IGT by GYN at 32 yo.
More informationComplete this CE activity online at ProCE.com/InsulinPart2
Complete this CE activity online at ProCE.com/InsulinPart2 Case 1: A 67 year old male with T2DM History and Presentation John is a 67 year old retiree who has been visiting your pharmacy/clinic for over
More informationDoctor s Instructions Patient: Mr Abdul Shareef Age: 40. Last Consultation Dr Mitchell 2 weeks ago
Doctor s Instructions Patient: Mr Abdul Shareef Age: 40 Last Consultation Dr Mitchell 2 weeks ago Telephone Triage: Patient just wants a routine blood test as FH of diabetes. Plan: Fasting blood test,
More informationApplication of the Diabetes Algorithm to a Patient
Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationVS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''
IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes
More informationRISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES
RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet
More informationPatient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE
Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE Dx/Hx: uncontrolled DM and HTN Lifestyle: Patient usually sleeps
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationCase study for CME Diabetes up-to-date management
Case study for CME Diabetes up-to-date management Dr Ole Schmiedel, MRCP MD FRACP Physician and Endocrinologist Service Clinical Director Auckland Diabetes Centre GP referral to Auckland Diabetes Centre
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationLearning Objectives
Learning Objectives Assess the key findings of the McMaster meal replacement therapy (MRT) study Identify patients with T2DM who are candidates for MRT Develop a plan to implement partial MRT into a patient
More informationPatient Case Mrs X Provided compliments of Mary Gunther, BScPharm, ACPR
Patient Case Mrs X Provided compliments of Mary Gunther, BScPharm, ACPR ID: Mrs X is a female in her mid sixties admitted for a CHF exacerbation CC: 1. 2 week history of increasing weakness, weight gain,
More informationRecord-Keeping Charts
In this appendix, we have provided some useful charts for you so you can record information that s important to manage your diabetes. Use these charts to keep track of the information not only for yourself,
More informationA Practical Approach to the Use of Diabetes Medications
A Practical Approach to the Use of Diabetes Medications Juan Pablo Frias, M.D., FACE President, National Research Institute, Los Angles, CA Clinical Faculty, University of California, San Diego, CA OUTLINE
More informationType 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA
Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the
More informationParticipants in the Program
Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the
More informationTreat-to-Target Tools
TEAMcare Care Manager Primary Care Provider Treat to Target Discussion Tool for Treatment Enhancement Activation and Motivation (TEAM) Depression, Diabetes and Coronary Heart Disease (CHD) Intervention
More informationDiabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018
Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity
More informationTEAMcare Treat-to-Target Tools
TEAMcare Treat-to-Target Tools The TEAMcare Treatment Discussion Tool (treatment protocol) Nurse Case Manager (NCM)-MD Treat-to-Target Discussion Tool for Treatment Enhancement Activation and Motivation
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationCASE STUDY #3 - NUT 116AL Diabetes Mellitus DUE Monday 12/9/13 (by 1:00pm in Meyer 3241)
Last Name Reagan First Name Jason Section 2_ CASE STUDY #3 - NUT 116AL Diabetes Mellitus DUE Monday 12/9/13 (by 1:00pm in Meyer 3241) Patricia C. is a 30 yo Asian American woman with T1DM. She was diagnosed
More informationAmerican Academy of Insurance Medicine
American Academy of Insurance Medicine October 2012 Dr. Alison Moy Liberty Mutual Dr. John Kirkpatrick Thrivent Financial for Lutherans 1 59 year old male, diagnosed with T2DM six months ago Nonsmoker
More informationA Process for Performing Medication Assessments
A Process for Performing Medication Assessments Derek Jorgenson, BSP, PharmD, FCSHP College of Pharmacy and Nutrition University of Saskatchewan Objectives 1. Learn an overview of a medication assessment
More informationAdvanced Pharmacology Diabetes Homework
Advanced Pharmacology Diabetes Homework Points: 25 Comments: Name: Tracy Hill WU ID #: 20015608 E-mail: tracy.hill@washburn.edu _TH I hereby certify that the work submitted is my own, and that I have not
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationCASE STUDY Diabetes Mellitus FH: PMH: Social Hx PE: Labs: Rx: CAM: Dx: Plan:
CASE STUDY Diabetes Mellitus Patricia C. is a 30 yo Asian American woman with T1DM. She was diagnosed at age 13. Her insulin regimen is 50 units of insulin (Glargine) every evening and 3 units of Lispro
More informationPrimary Care Patient Case Example
Primary Care Patient Case Example Chief Complaint (CC): K.G. presents to your clinic for a follow-up. You work in an interprofessional clinic with physicians. He has no complaints today. History of the
More informationLearning Objectives. Outline 4/3/2018. Treatment Strategies to Maximize the Value of Diabetes Medications
Treatment Strategies to Maximize the Value of Diabetes Medications Presenters: Jennifer Toy, PharmD, BCACP and Crystal Zhou, PharmD, APh AHSCP, BCACP Learning Objectives 1. Discuss which patients may benefit
More informationDate of Birth. Black/African American. What is your occupation? Retired? Yes No
Health Risk Assessment Today s Date: Name Date of Birth GENERAL INFORMATION What is your race? American Indian or Alaskan Native Native Hawaiian or Other Pacific Islander Asian, Chinese, Japanese, Korean
More informationType 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.
Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to
More informationHealth Risk Assessment
Health Risk Assessment Today s Date: Name Date of Birth GENERAL INFORMATION What is your race? American Indian or Alaskan Native Native Hawaiian or Other Pacific Islander Asian, Chinese, Black/African
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationHelping You Manage Your Diabetes
CVS Caremark Pharmacy Advisor Program Helping You Manage Your Diabetes Pharmacy Advisor Program Helping You Manage Your Diabetes Contents Know Your Diabetes...4 Medications to Lower Your Risk of Diabetes-Related
More informationInsulin Optimisation Workshop. Theingi Aung & Claire Rowell
Insulin Optimisation Workshop Theingi Aung & Claire Rowell Insulin initiation and titration Insulin Preparations Rapid-acting insulin analogues: onset of action of approximately 15 minutes and a duration
More informationTop 5 (Topics) Papers In GIM Rocky Mountain ACP Internal Medicine Meeting Raj Padwal November 13, 2008
Top 5 (Topics) Papers In GIM 2008 Rocky Mountain ACP Internal Medicine Meeting Raj Padwal November 13, 2008 Methods Searched ACPJC/EBM, TOC of top medical journals, MEDSCAPE Best Evidence, consultation
More informationOBESITY IN TYPE 2 DIABETES
OBESITY IN TYPE 2 DIABETES Ashley Crowl, PharmD, BCACP Assistant Professor University of Kansas Objectives Review how to manage obesity in patients with type-2 diabetes mellitus Compare antiobesity agents
More informationTopic: Chronic Heart Failure Cases for Monday s March 21th lecture.
1 Phar6122: CV section Date: 3/10/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In
More information51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD
51 year old woman with hyperglycemia August 9, 2012 Katie Stanley, MD HPI Diagnosed with DM 1 year prior to visit Established primary care at that time due to notable weight loss after tobacco cessation
More informationPHYSICIANS INTERACTIVE PARTICIPANT GUIDE
PHYSICIANS INTERACTIVE PARTICIPANT GUIDE Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationThe York Diabetes Care Model
This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin
More informationType 2 Diabetes Mellitus Insulin Therapy 2012
Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration
More informationWELL-WOMAN EXAM REVEALS RISK. Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University
WELL-WOMAN EXAM REVEALS RISK Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University Disclaimer The information provided in this presentation is for informational
More informationCase study: Individual with inadequate glycaemic control due to poor adherence to medication
Case study: Individual with inadequate glycaemic control due to poor adherence to medication Authored by Linong Ji and Clifford Bailey on behalf of the Global Partnership for Effective Diabetes Management.
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationMore Than Just the Numbers:
More Than Just the Numbers: Individualising Patient Care ADEA-QLD Branch Conference 20 April 2018 Case Study 1 Child with Type 1 Diabetes 2 Background and Social History 10 year old female with T1DM since
More informationInsulin Initiation, titration & Insulin switch in the Primary Care-KISS
Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda
More informationPlanned Interventions
Risk Factors Exercise Diabetes Hypertension Tobacco Use Initial Status Patient is currently exercising: More than 150 minutes Less than 150 minutes Per Week Type 1 Type 2 Borderline Diabetic :HgA1c < 6.5%;
More informationDisclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?
Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09
More informationAddressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:
Addressing Challenges in Type 2 Diabetes Geneva Briggs, PharmD,, BCPS Addressing Challenges in Type 2 Diabetes Speaker: Dr. Geneva Clark Briggs, a board-certified Pharmacotherapy Specialist, received her
More informationDiabetes Self-Management Education Record
Diabetes Self-Management Education Record Patient Label Record level of competence and Initial: O=outcomes met; RT=reinforce teaching; NA=not applicable; P=prior knowledge Clinical Outcomes Information
More informationConflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines
Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy
More informationImproving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies
Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Leigh Briscoe-Dwyer, PharmD, BCPS, FASHP Chief Pharmacy and Medication Safety Officer North Shore Long Island Jewish Health
More informationCase study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease
Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease Authored by Paul Zimmet and Richard Nesto on behalf of the Global Partnership for Effective Diabetes Management.
More informationMixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
More informationSubjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per
APPENDIX 1 Insulin Titration Algorithm Subjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per day. All subjects will be contacted weekly to review hypoglycemia and adverse
More informationCKD & HT. Anne-Marie Angus
CKD & HT Anne-Marie Angus Hypertension definitions Persisting BP >140/90 and HBPM >135/85 Stage 1 >140/90 (HBPM >135/85) Stage 2 >160/100 (HBPM >150/90) Severe >180/100 White coat HT Why treat? A major
More informationIMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS
IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes
More informationDiabetes Overview. How Food is Digested
Diabetes Overview You are The Teacher, The Coach and the Fan Pathophysiology of Diabetes Complications Know the Numbers Treatment Can Good Control Make a Difference? Can Tight Control Be too Tight? How
More informationNEW DIABETES CARE MEDICATIONS
NEW DIABETES CARE MEDICATIONS James Bonucchi DO, ECNU, FACE Adult Medicine and Endocrinology Specialists Disclosures Speakers bureau Sanofi AZ BI Diabetes Diabetes cost ADA 2017 data Ever increasing disorder.
More informationAPhA March 2016 Annual Meeting Obesity Cases
APhA March 2016 Annual Meeting Obesity Cases Case #1 Pam is a 47 yo obese Caucasian woman; grade school teacher with a history of HTN, HoTR, and depression who presents for her annual physical. CC: I m
More informationAppendix A: Sample Patient Profiles and Prescriptions
Appendix A: Sample Patient Profiles and Prescriptions (For Pharmacist Use) Sample Patient Profile 1 Name Mike Monroe Date of Birth 01/01/1957 Address 555 Happy Lane Phone 123-456-7890 Tucson, AZ 85704
More informationCASES: DIABETES AND PREGNANCY
CASE 1: Visit 1: Ms. Sunny Disposition is a 32 yo G2P1001 who is approximately 15 weeks here for her first prenatal visit. She has already had an US but records not yet received. Pmhx: Unremarkable, no
More informationROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP
ROAD TO UNDERSTANDING POLYPHARMACY Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP Definition occurs when: 1. a medical regimen includes at least one unnecessary medication 2. Medications have not been
More informationEndocrinology TeleECHO Clinic Case Presentation Form
Endocrinology TeleECHO Clinic Case Presentation Form Complete ALL ITEMS on this form and fax to 503.228.4801 PLEASE NOTE that case consultations do not create or otherwise establish a provider-patient
More informationWelcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1
Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationCHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia
CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia Javier Carrasco, MD, PhD Juan Ramón Jiménez Hospital University of Huelva, Spain Case Study: Medical and Social History A 60 years old female
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationInsulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology
Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss
More informationCase Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic
Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for
More informationJournal Club September 29, Vanessa AKIKI PGYlII Internal Medicine
Journal Club September 29, 2017 Vanessa AKIKI PGYlII Internal Medicine AUBMC 2017 Case Presentation 41-year-old man who was diagnosed with type 1 diabetes 21 years ago presents to your clinic. He believes
More informationIntensification of Diabetic Therapy. Case studies
Intensification of Diabetic Therapy Case studies Patient #1 1 st visit: 64 year old male, H/O prediabetes, lost weight 280 lbs. to 240 lbs. ER for dental abscess, glucose >300 A1C 11.4%, no diabetic medication,
More informationSample Exam Questions
Disclaimer These are not validated questions. They have been created to enhance your learning and provide practice in reading and answering multiple choice questions. Some questions have been created to
More informationManagement of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE
Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent
More informationPrediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes!
Prediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes! Jaini Patel, PharmD, BCACP Assistant Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Kathleen
More informationMyAction Couple: Primary Prevention Case Study. Teresa Mackay, Rhian Houghton, Tim Grove
MyAction Couple: Primary Prevention Case Study Teresa Mackay, Rhian Houghton, Tim Grove Reason for Referral and Patient Demographics Referral Mr Smith Referred by GP High CVD 34.5% QRISK Hypertension (155/92)
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationPrediabetes Prediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes! Disclosures/Conflict of Interest.
Prediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes! Jaini Patel, PharmD, BCACP Assistant Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Kathleen
More informationHow to Reduce CVD Complications in Diabetes?
How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year
More informationLong-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA
Long-Term Management Of the ACS Patient: State-of-the-Art Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA Disclosures I have no disclosures. Case Study 45 y/o male admitted to
More informationMedicare Wellness. Meggan Robinson, DO MAOFP Spring Update 4/23/16
Medicare Wellness Meggan Robinson, DO MAOFP Spring Update 4/23/16 Objectives History of Medicare Wellness Exam Identify the goals of the Wellness exam Differentiate the different types of Wellness exams
More informationType 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I
Type 1 Diabetes Mellitus in the Adult Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Diabetes Mellitus: Type I Genetic factor Sudden onset Majority children and adolescents with an increasing
More informationZetia and Byetta Can Kill (and other recent DM headlines)
Zetia and Byetta Can Kill (and other recent DM headlines) Jennifer Beach, Pharm.D., CDE UWMC Diabetes Care Center Prandial Percolations Part 4 November 18, 2008: Tacoma ZETIA kills? Data from the Simvastatin
More informationLow HDL-levels: leave it or treat it?
Cardiology Update 2011 Davos, 14 02 2011 Low HDL-levels: leave it or treat it? Experts: J.P. Kastelein, Amsterdam and U. Landmesser, Zurich Cases: C. Besler, Zurich and I. Sudano, Zurich Mr H.B., 1960
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationWelcome to Diabetes MiniSeries Course 2
Welcome to Diabetes MiniSeries Course 2 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2014, Diabetes Education Services, All Rights Reserved. Diabetes
More informationDiabetes Mellitus: Implications of New Clinical Trials and New Medications
Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October
More informationPharmacology Challenges: Managing Statin Myalgia
Clinical Case: RM is a 50 year-old African American woman with a past medical history of type diabetes, dyslipidemia, hypertension and peripheral arterial disease. She had been prescribed simvastatin 80
More informationCrossing The Quality Chasm: Cardiovascular Care
Crossing The Quality Chasm: Cardiovascular Care Philip Madvig, MD Associate Executive Director Partnership for Quality Care Chronic Disease Summit March 19, 2008 The Impact of Cardiovascular Disease In
More informationControversies in Preventative Cardiology
Controversies in Preventative Cardiology Francisco Lopez-Jimenez, M.D., M.Sc, FACC, FAHA Professor of Medicine, Mayo Medical School Chair, Division of Preventive Cardiology Co-Director, Artificial Intelligence
More informationAPPENDIX American Diabetes Association. Published online at
APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no
More informationCURRENT ISSUES IN DIABETES MANAGEMENT. Screening for Diabetes Advantages of HbA1c as a Diagnostic Test. Diagnosis of Diabetes 2013
CURRENT ISSUES IN DIABETES MANAGEMENT Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Screening for Diabetes 2013 BMI
More informationThe future is here. It s just not widely distributed yet. William Gibson
The future is here. It s just not widely distributed yet. William Gibson CHRONIC KIDNEY DISEASE MANAGEMENT A NEW PARADIGM Aaron Cass, MD, FRCPC Nephrologist, Fraser Health January 22, 2014 Where Are We
More informationDiabetes Treatment Update
Diabetes Treatment Update Timothy C. Evans, MD PhD FACP University of Washington Department of Medicine Disclosure: Dr. Evans has no significant financial interest in any of the products or manufacturers
More informationPharmacy Partnership to Improve Patient Outcomes
Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners
More informationDeveloped by the Hannibal Regional Hospital Diabetes and Wound Ostomy Center as part of the Better Self Management of Diabetes program, funded by the
Developed by the Hannibal Regional Hospital Diabetes and Wound Ostomy Center as part of the Better Self Management of Diabetes program, funded by the Missouri Foundation for Health. BSMOD Organizational
More informationDIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:
1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationObjectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
More informationSponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More information